Every ticket sold makes a difference. Thanks to the generous support of our Home Lottery, we are achieving the extraordinary. 

Life saving equipment used in our intensive care unit can come from Home Lottery funds

The Royal Melbourne Hospital Home Lottery has funded a large number of projects both big and small.

Over $5 million has been invested in critical medical research of:

  • stroke
  • brain tumours
  • multiple sclerosis
  • atrial fibrillation (heart arrhythmmia)

Over $1.5 million of state-of-the-art medical equipment has been funded, including:

  • New beds for our Orygen Youth Health Inpatient Unit
  • A new CMAC Intubation Unit to treat patients with significant airway obstructions
  • Two E-Pen electric drills to reduce operation time in certain procedures

Over $1 million has been invested in upgrading our level of care.

Over $2 million has contributed to major Hospital renovation projects.

Projects big and small

$300,000 to replace endoscopic equipment in ward 3 West for day procedure patients

$35,000 to provide a new remote release blood bank system, that provides a greatly improved storage and more secure management system of blood products.

$650,000 to fund a professor of Allied Health, which will strengthen the relationship between research and patient care. It will also deliver academic leadership and cutting edge research in Allied Health practice.

$250,000 to fund the intelligent fungal surveillance system (iFSS) which will provide a clinical support system to enable automated surveillance of invasive fungal infections. This will improve time to diagnosis and management of invasive fungal infections and provide a means of monitoring outbreaks and trends, which is not currently possible.

$10,000 to provide new syringe drivers for critical care patients in the emergency department.

$45,000 to install infrastructure for enhanced clinical and social communication through the use of contemporary technology, across 7 residential aged persons mental health facilities.

$140,000 to equip and install a new ultrasound simulator training package that will assist in improving clinical standards and improve clinical and diagnostic efficiency. It will enable clinicians across critical care, anaesthesia, ICU, surgery and emergency medicine to more readily access ultrasound simulation training.

$53,000 to replace the emergency department ultrasound machine.

$25,000 to go towards the development of skin-mounted temperature sensors to provide continuous remote monitoring of skin temperature for early identification of infection in high-risk patients.

$37,000 to go towards stage 1 of the expansion of day medical treatment spaces.

$11,000 to develop a falls prevention video for older patients.

Sam Kalogiannopoulos suffered a major stroke but the EXTEND-IA treatment greatly improved his outcome

EXTEND-IA - Testing the effectiveness of a new minimally invasive treatment to re-open blocked arteries in stroke patients

The only currently proven treatment to re-open blocked arteries in stroke patients (dissolving the clot with intravenous drugs) reduces disability but frequently fails to re-open large blocked arteries. Minimally invasive clot "retrieval" procedures via angiogram promise increased vessel opening but remain untested in randomized trials. This trial will formally test the efficacy of clot retrieval.

MRI biomarkers for patients with brain tumors causing optic chiasm compression

The results of this first of its kind study should pave the way for further research utilising these MRI techniques in patients with these and other types of brain tumours. This study will also help us better understand the structure and function of the visual pathway. These advanced MRI techniques can be translated into clinical practice to improve and individualise the management of patients with these types of brain tumours.

Genetic markers of MS prognosis in the RMH outpatient cohort

In this project, using the resource of known and well-recorded long-term outcomes in the Royal Melbourne Hospital MS clinic, we hope to conduct a genetic study to see if we can a) validate proposed genetic markers of disease severity and b) find new ones.

This project has the capacity for rapid translation into clinical practice, and could practically inform the risk/benefit discussion with MS patients in relation to the increasing number of therapies available at present.

Rate, predictors and markers of left atrial remodeling in paroxysmal and persistent atrial fibrillation

Atrial fibrillation is a common and serious disturbance in the rhythm of the heart. The study will involves the development of blood tests and of an ultrasound imaging test of the heart, to study in detail the structure and function of the left atrium, the region in the heart from which atrial fibrillation originates. The current test for this condition is an invasive cardiac procedure.

We will compare the results of this invasive test with the results of our non-invasive tests and expect to demonstrate that atrial fibrillation is a progressive condition, and is itself an important determinant of the rate of progression. We expect that the non-invasive tests will be found to correlate well with the results of the invasive test.